drugset / Trial / NCT00452790
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC) compared to Prevenar (7vPnC), when given concomitantly with routine paediatric vaccinations in India.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-10
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prevnar 13 | Vaccine | — | — |